LRRC75B

gene
On this page

Also known as MGC131773

Summary

LRRC75B (leucine rich repeat containing 75B, HGNC:33155) is a protein-coding gene on chromosome 22q11.23, encoding Leucine-rich repeat-containing protein 75B (Q2VPJ9). May suppress myogenic differentiation by modulating MYOG expression and Erk1/2 signaling.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 1 total
  • MANE Select transcript: NM_207644

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:33155
Approved symbolLRRC75B
Nameleucine rich repeat containing 75B
Location22q11.23
Locus typegene with protein product
StatusApproved
AliasesMGC131773
Ensembl geneENSG00000178026
Ensembl biotypeprotein_coding
Entrez388886

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 4 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000318753, ENST00000404045, ENST00000446942, ENST00000460524, ENST00000464490, ENST00000465334, ENST00000491910, ENST00000495297, ENST00000876360, ENST00000876361, ENST00000935984

RefSeq mRNA: 1 — MANE Select: NM_207644 NM_207644

CCDS: CCDS42991

Canonical transcript exons

ENST00000318753 — 4 exons

ExonStartEnd
ENSE000017538542459286324593073
ENSE000034582212458563524586411
ENSE000035797322458821424588329
ENSE000036496092458982124589949

Expression profiles

Bgee: expression breadth ubiquitous, 212 present calls, max score 95.69.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.1976 / max 65.6521, expressed in 1412 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1933874.19761412

Top tissues by expression

228 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
kidney epitheliumUBERON:000481995.69silver quality
parotid glandUBERON:000183193.66silver quality
vena cavaUBERON:000408793.33silver quality
right lobe of liverUBERON:000111493.25gold quality
left lobe of thyroid glandUBERON:000112093.08gold quality
right lobe of thyroid glandUBERON:000111992.83gold quality
thyroid glandUBERON:000204692.72gold quality
lateral nuclear group of thalamusUBERON:000273691.79silver quality
lateral globus pallidusUBERON:000247691.65silver quality
lower esophagus mucosaUBERON:003583490.63gold quality
body of tongueUBERON:001187690.46silver quality
ventral tegmental areaUBERON:000269189.85silver quality
ponsUBERON:000098889.81silver quality
tongueUBERON:000172389.70silver quality
pharyngeal mucosaUBERON:000035589.61silver quality
tracheaUBERON:000312689.46silver quality
metanephros cortexUBERON:001053389.41gold quality
pylorusUBERON:000116689.16silver quality
medulla oblongataUBERON:000189688.86silver quality
substantia nigra pars compactaUBERON:000196588.83silver quality
superior vestibular nucleusUBERON:000722788.77silver quality
ventricular zoneUBERON:000305388.66gold quality
cerebellar vermisUBERON:000472088.56gold quality
prostate glandUBERON:000236788.52gold quality
inferior vagus X ganglionUBERON:000536388.42silver quality
trigeminal ganglionUBERON:000167588.41silver quality
tibial nerveUBERON:000132388.39gold quality
superior surface of tongueUBERON:000737188.35silver quality
fundus of stomachUBERON:000116088.34gold quality
dorsal root ganglionUBERON:000004488.06silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.08

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

9 targeting LRRC75B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-63699.8069.581500
HSA-MIR-6757-3P99.6366.881089
HSA-MIR-466399.6265.33957
HSA-MIR-6794-3P98.7666.99894
HSA-MIR-63797.9164.051517
HSA-MIR-7112-3P97.6768.77948
HSA-MIR-125B-2-3P96.6968.381210
HSA-MIR-668-3P96.1865.80673
HSA-MIR-6785-3P86.7566.4945

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusLrrc75bENSMUSG00000046807
rattus_norvegicusLrrc75bENSRNOG00000075066

Protein

Protein identifiers

Leucine-rich repeat-containing protein 75BQ2VPJ9 (reviewed: Q2VPJ9)

Alternative names: Leucine-rich repeat-containing protein FAM211B

All UniProt accessions (3): F8WCG9, F8WCZ7, Q2VPJ9

UniProt curated annotations — full annotation on UniProt →

Function. May suppress myogenic differentiation by modulating MYOG expression and Erk1/2 signaling.

Similarity. Belongs to the LRRC75 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q2VPJ9-11yes
Q2VPJ9-22

RefSeq proteins (1): NP_997527* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR032675LRR_dom_sfHomologous_superfamily

UniProt features (10 total): repeat 2, region of interest 2, compositionally biased region 2, splice variant 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q2VPJ9-F173.050.37

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 66 (showing top): ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP, EBNA1BP2_TARGET_GENES, ZBTB12_TARGET_GENES, GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP, MIR636, GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN, GSE14308_TH1_VS_INDUCED_TREG_UP, GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP, DESCARTES_MAIN_FETAL_DUCTAL_CELLS, PSIP1_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

96 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LRRC75BC22orf15Q8WYQ4718
LRRC75BDRICH1Q6PGQ1622
LRRC75BGUCD1Q96NT3591
LRRC75BPROSER2Q86WR7581
LRRC75BZNF70Q9UC06571
LRRC75BGSTT4A0A1W2PR19567
LRRC75BDDTLA6NHG4542
LRRC75BRGL4Q8IZJ4507
LRRC75BSTOML1Q9UBI4448
LRRC75BSPECC1LQ69YQ0434
LRRC75BUPB1Q9UBR1419
LRRC75BH7C1H1H7C1H1418
LRRC75BSLC2A11Q9BYW1417
LRRC75BVPREB3Q9UKI3395
LRRC75BCHRNA1P02708384

IntAct

0 interactions, top by confidence:

BioGRID (2): LRRC75B (Affinity Capture-RNA), LRRC75B (Positive Genetic)

ESM2 similar proteins: A0A1W2PP97, A6NLX4, A6QNY1, P0DJK0, P12838, P13207, P22389, P22749, P23943, P29473, P29474, P55056, P70313, P79209, P97270, P98162, Q1RMT9, Q28969, Q2TAL6, Q2VPJ9, Q4TUC0, Q566C8, Q5BIR3, Q5JTB6, Q5NRP8, Q5RCS3, Q5SPX3, Q5XIX0, Q62600, Q64322, Q7TMJ8, Q7TPD7, Q7TSF4, Q80TT8, Q867D0, Q8BZT7, Q8C8N3, Q8K1T4, Q8K4Z2, Q8MJW9

Diamond homologs: Q2VPJ9, Q7TPD7, Q7TSF4, Q8NAA5, P78395

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1450 predictions. Top by Δscore:

VariantEffectΔscore
22:24588209:CTTA:Cdonor_loss1.0000
22:24588210:TTA:Tdonor_loss1.0000
22:24588211:TA:Tdonor_loss1.0000
22:24588212:A:ACdonor_gain1.0000
22:24588212:A:AGdonor_loss1.0000
22:24588213:C:CCdonor_gain1.0000
22:24588213:CCAG:Cdonor_gain1.0000
22:24588227:T:TAdonor_gain1.0000
22:24588325:TAGTC:Tacceptor_gain1.0000
22:24588327:GTC:Gacceptor_gain1.0000
22:24588328:TC:Tacceptor_gain1.0000
22:24588329:CC:Cacceptor_gain1.0000
22:24588329:CCTG:Cacceptor_loss1.0000
22:24588330:C:CCacceptor_gain1.0000
22:24588331:T:Gacceptor_loss1.0000
22:24589817:TCA:Tdonor_loss1.0000
22:24589820:C:CGdonor_loss1.0000
22:24589820:CCTT:Cdonor_gain1.0000
22:24589945:AGGTC:Aacceptor_gain1.0000
22:24589946:GGTC:Gacceptor_gain1.0000
22:24589948:TC:Tacceptor_gain1.0000
22:24589949:CCTG:Cacceptor_gain1.0000
22:24589959:G:Cacceptor_gain1.0000
22:24589959:G:GCacceptor_gain1.0000
22:24592822:C:CAdonor_gain1.0000
22:24592852:C:CAdonor_gain1.0000
22:24586412:C:CCacceptor_gain0.9900
22:24588207:CCCTT:Cdonor_loss0.9900
22:24588326:AGTC:Aacceptor_gain0.9900
22:24589819:A:ACdonor_gain0.9900

AlphaMissense

1980 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
22:24586267:G:CF189L0.979
22:24586267:G:TF189L0.979
22:24586269:A:GF189L0.979
22:24586120:G:CF238L0.945
22:24586120:G:TF238L0.945
22:24586122:A:GF238L0.945
22:24592927:A:GI38T0.940
22:24586087:G:CN249K0.922
22:24586087:G:TN249K0.922
22:24586270:G:CS188R0.919
22:24586270:G:TS188R0.919
22:24586272:T:GS188R0.919
22:24586121:A:GF238S0.915
22:24586180:G:CN218K0.908
22:24586180:G:TN218K0.908
22:24586184:C:AG217V0.907
22:24586090:G:CN248K0.905
22:24586090:G:TN248K0.905
22:24592940:A:GW34R0.884
22:24592940:A:TW34R0.884
22:24592936:A:TL35H0.883
22:24586196:A:TL213H0.880
22:24588286:A:TL117H0.879
22:24586196:A:GL213P0.876
22:24588286:A:GL117P0.876
22:24586091:T:AN248I0.867
22:24586107:A:GW243R0.867
22:24586107:A:TW243R0.867
22:24592927:A:CI38S0.864
22:24586190:A:TL215H0.859

dbSNP variants (sampled 300 via entrez): RS1000232388 (22:24588993 C>T), RS1000266797 (22:24589237 A>G), RS1000616149 (22:24587452 C>T), RS1000643265 (22:24593127 A>G), RS1001009331 (22:24585860 T>C), RS1001230668 (22:24589221 A>G), RS1001270770 (22:24590883 C>T), RS1001283155 (22:24589457 G>A), RS1001711695 (22:24585637 G>A), RS1001837618 (22:24585136 C>T), RS1002179047 (22:24594113 C>T), RS1002278377 (22:24592496 C>G), RS1002313012 (22:24586539 C>G,T), RS1002413627 (22:24586703 G>A,C), RS1002721252 (22:24594350 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST000248_7Liver enzyme levels4.000000e-11
GCST001234_7Gamma glutamyl transpeptidase7.000000e-53
GCST002481_6Acne (severe)6.000000e-07
GCST90013407_1Liver enzyme levels (gamma-glutamyl transferase)1.000000e-300

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004532serum gamma-glutamyl transferase measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, increases methylation2
aristolochic acid Idecreases expression1
GSK-J4decreases expression1
afuresertibincreases expression1
triphenyl phosphateaffects expression1
bisphenol Aincreases expression1
sodium arsenitedecreases expression1
abrinedecreases expression1
jinfukangaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Zoledronic Aciddecreases expression1
Vorinostatdecreases expression1
Air Pollutantsincreases abundance, increases expression1
Cadmiumdecreases expression, increases abundance1
Calcitriolincreases expression, affects cotreatment1
Cisplatinaffects cotreatment, increases expression1
Estradiolaffects cotreatment, increases expression1
Niclosamideincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Smokedecreases expression1
Testosteroneaffects cotreatment, increases expression1
Thimerosaldecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Valproic Acidaffects expression1
1-Methyl-4-phenylpyridiniumincreases expression1
Cyclosporinedecreases expression1
Cadmium Chloridedecreases expression, increases abundance1
Palmitic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.